Safety and Efficacy of Topical Recombinant Human Thrombin(rhThrombin) for Surgical Hemostasis

PHASE3CompletedINTERVENTIONAL
Enrollment

348

Participants

Timeline

Start Date

November 11, 2019

Primary Completion Date

October 20, 2021

Study Completion Date

October 20, 2021

Conditions
Surgical Hemostasis
Interventions
BIOLOGICAL

recombinant human Thrombin(CHO cell)

2 rhThrombin, dissolved in 5mL sterile saline and mixed, the final solution contains 1000IU/mL rhThrombin solution (clear and transparent liquid).

BIOLOGICAL

placebo

placebo, dissolved in 5mL sterile saline and mixed, the final solution contains 1000IU/mL rhThrombin solution (clear and transparent liquid).

Trial Locations (1)

Unknown

The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou

All Listed Sponsors
lead

Suzhou Zelgen Biopharmaceuticals Co.,Ltd

INDUSTRY

NCT04459871 - Safety and Efficacy of Topical Recombinant Human Thrombin(rhThrombin) for Surgical Hemostasis | Biotech Hunter | Biotech Hunter